ClinicalTrials.Veeva

Menu

Treating Smokers With Mental Illness

University of Minnesota (UMN) logo

University of Minnesota (UMN)

Status and phase

Completed
Phase 2

Conditions

Major Depressive Disorder
Psychotic Disorders
Cigarette Smoking
Bipolar II Disorder
Bipolar Disorder I
Mental Illness
Schizophrenia
Smoking Cessation

Treatments

Drug: Nicotine patch
Drug: Nicotine lozenge
Behavioral: Therapy
Other: Information

Study type

Interventional

Funder types

Other

Identifiers

NCT03822416
SPH-2018-26854

Details and patient eligibility

About

This is a smoking cessation study that will enroll smokers who have been diagnosed with a severe mental illness. The study will use a combination of intensive tobacco treatment counseling and nicotine replacement therapy to assist smokers in cutting back on and quitting smoking over the course of six months.

Full description

At the baseline measurement visit, participants will be asked to complete a survey and an interview. They will be randomly assigned to either the intervention or control group. Both groups will receive a smoking cessation manual and list of resources. The intervention group will also receive smoking cessation counseling and nicotine replacement therapy. Both groups will be seen for in-person assessments again at 8 weeks and 6 months post baseline.

Enrollment

38 patients

Sex

All

Ages

18 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • have a severe mental illness diagnosis
  • be a daily smoker
  • be willing to reduce the number of cigarettes smoked per day leading to a quit attempt
  • want to try to quit smoking
  • be willing to use nicotine replacement therapy
  • be able to communicate in English

Exclusion criteria

  • anyone who has had an active psychotic episode or been hospitalized due to suicidal ideation in the last six months
  • pregnancy
  • taking Chantix or Clozapine
  • having a terminal illness

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

38 participants in 2 patient groups

Intervention
Experimental group
Description:
Intervention group will receive counseling and nicotine replacement therapy including the nicotine patch and/or nicotine lozenges.
Treatment:
Drug: Nicotine patch
Drug: Nicotine lozenge
Other: Information
Behavioral: Therapy
Control
Other group
Description:
Control group will receive information about mental illness and smoking cessation and a listing of community resources available for assistance with smoking cessation.
Treatment:
Other: Information

Trial documents
2

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems